Milrinone improves arterial oxygenation in dogs with acute lung injury induced by oleic acid

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 6, 1999, Pages 806-810

  Tanaka, Hiroyuki ^a,b   Tajimi, Kimitaka ^a   Kobayashi, Kunio ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Acute lung injury; Arterial oxygenation; Extravascular lung thermal volume; Milrinone; Phosphodiesterase inhibitor

Indexed keywords

MILRINONE; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN SATURATION; ARTICLE; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; DOG; DRUG EFFICACY; EXTRAVASCULAR SPACE; HEART INDEX; LUNG INJURY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; CARDIAC OUTPUT; DOGS; EXTRAVASCULAR LUNG WATER; HEMODYNAMIC PROCESSES; MILRINONE; OLEIC ACID; OXYGEN; OXYGEN CONSUMPTION; PHOSPHODIESTERASE INHIBITORS; PULMONARY CIRCULATION; PULMONARY EDEMA; TIME FACTORS;

EID: 0032725463     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199912000-00006     Document Type: Article

References (20)

1. Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA. Cardiotonic activity of milrinone, a new and potent bipyridine, on the normal and failing heart of experimental animals. J Cardiovasc Pharmacol 1983;5:792-803.
2. Jaski BF, Fifer MA, Wright RF, Braunwald E, Colucci WS. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest 1985;75:643-9.
3. Honerjager P. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 1991;121:1939-44.
4. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotide. J Pharmacol Exp Ther 1987;242:864-72.
5. Rossing TH, Drazen JM. Effects of milrinone on contractile responses of guinea pig trachea, lung parenchyma and pulmonary artery. J Pharmacol Exp Ther 1986;238:874-9.
6. Mathew R, Wang J, Gewitz MH, Hintze TH, Wolin MS. Congestive heart failure alters receptor-dependent cAMP-mediated relaxation of canine pulmonary arteries. Circulation 1993;87:1722-8.
7. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K. Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism. Clin Exp Pharmacol Physiol 1990;19:681-90.
8. Tanaka H, Tajimi K, Moritsune O, Kobayashi K, Okada K. Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit Care Med 1991;19:68-74.
9. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K. Effects of milrinone on lung water content in dogs with pulmonary hypertension. J Pharmacol Toxicol Methods 1992;28:201-8.
10. Hopkins NK, Gorman R. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest 1981;67: 540-6.
11. Holbrock M, Coker J. Comparison of the effects of isobutylmethylxanthine and milrinone on ischemia-induced arrhythmia and platelet aggregation in anesthetized rabbits. Br J Pharmacol 1989; 98:318-24.
12. Ishibe Y, Suekane K, Nakamura M, et al. Measurement of lung water with double indicator dilution methods using heat and sodium ions in dogs. Jpn Anesth J Rev 1987;2:5-7.
13. Effros RM. Lung water measurements with the mean transit time approach. J Appl Physiol 1985;59:673-83.
14. Thompson HK Jr, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variant. Circ Res 1964; 14:502-15.
15. Sum-ping ST, Symreng T, Jebson P, Kamal GD. Stable and reproductive porcine model of acute lung injury induced by oleic acid. Crit Care Med 1991;19:405-8.
16. Silver PJ, Lepore RE, O'Connor B, et al. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. J Pharmacol Exp Ther 1989;247:34-42.
17. Post M, Biesebeek JD, van Rooij HH, Wemer J, Porsins AJ. Anti-allergic effects of milrinone and sulmazole in isolated rat lungs in comparison with theophylline. Int Arch Allergy Appl Immunol 1989;89:1-5.
18. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995;75:725-48.
19. Conti M, Nemoz G, Sette C, Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterase. Endocr Rev 1995;16:370-89.
20. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 1996;28:1775-80.